HR

Heinrich Röder

BI Biodesix: 40 patents #1 of 32Top 4%
GL Globeimmune: 2 patents #15 of 23Top 70%
IR Institute For Cancer Research: 1 patents #33 of 104Top 35%
University Of Texas System: 1 patents #2,951 of 6,559Top 45%
TK Trumpf Kreuzer Medizin Systeme Gmbh + Co. Kg: 1 patents #2 of 8Top 25%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
📍 Steamboat Springs, CO: #5 of 99 inventorsTop 6%
🗺 Colorado: #558 of 40,980 inventorsTop 2%
Overall (All Time): #69,050 of 4,157,543Top 2%
43
Patents All Time

Issued Patents All Time

Showing 1–25 of 43 patents

Patent #TitleCo-InventorsDate
12230398 Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods Joanna Röder, Krista Meyer, Julia Grigorieva, Maxim Tsypin, Carlos Oliveira +4 more 2025-02-18
12094587 Apparatus and method for identification of primary immune resistance in cancer patients Carlos Oliveira, Joanna Röder 2024-09-17
11894147 Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings Thomas A. Campbell, Robert W. Georgantas, III, Joanna Röder, Laura Maguire 2024-02-06
11710539 Predictive test for melanoma patient benefit from interleukin-2 (IL2) therapy Arni Steingrimsson, Carlos Oliveira, Krista Meyer, Joanna Röder 2023-07-25
11621057 Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy Arni Steingrimsson, Joanna Röder, Julia Grigorieva, Krista Meyer 2023-04-04
11594403 Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blood-based sample Arni Steingrimsson, Joanna Röder 2023-02-28
11476003 Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings Thomas A. Campbell, Robert W. Georgantas, III, Joanna Röder, Laura Maguire 2022-10-18
11150238 Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups Carlos Oliveira, Julia Grigorieva, Joanna Röder 2021-10-19
10950348 Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods Joanna Röder, Krista Meyer, Julia Grigorieva, Maxim Tsypin, Carlos Oliveira +4 more 2021-03-16
10713590 Bagged filtering method for selection and deselection of features for classification Joanna Röder, Arni Steingrimsson, Carlos Oliveira 2020-07-14
10593529 Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies Joanna Röder 2020-03-17
10489550 Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample Joanna Röder, Carlos Oliveira 2019-11-26
10436795 Carbon-detected NMR for mapping binding sites in intrinsically disordered regions of a protein Hong Cheng 2019-10-08
10217620 Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry Joanna Röder, Carlos Oliveira, Julia Grigorieva, Devalingam Mahalingam 2019-02-26
10037874 Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry Joanna Röder, Carlos Oliveira, Julia Grigorieva, Devalingam Mahalingam 2018-07-31
10007766 Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods Joanna Röder, Krista Meyer, Julia Grigorieva, Maxim Tsypin, Carlos Oliveira +5 more 2018-06-26
9824182 Method and system for determining whether a drug will be effective on a patient with a disease Maxim Tsypin, Julia Grigorieva 2017-11-21
9779204 Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample Joanna Röder, Carlos Oliveira 2017-10-03
9653272 Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies Joanna Röder 2017-05-16
9606101 Deep MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof Senait Asmellash, Jenna Allen, Maxim Tsypin 2017-03-28
9563744 Method of predicting development and severity of graft-versus-host disease Joanna Röder 2017-02-07
9477906 Classification generation method using combination of mini-classifiers with regularization and uses thereof Joanna Röder 2016-10-25
9279798 Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof Senait Asmellash, Jenna Allen, Maxim Tsypin 2016-03-08
9254120 Method for predicting breast cancer patient response to combination therapy Joanna Röder, Julia Grigorieva 2016-02-09
9211314 Treatment selection for lung cancer patients using mass spectrum of blood-based sample Joanna Röder 2015-12-15